Trial Profile
Buprenorphine Extended-release in Jail and at Re-entry: Open-label Randomized Controlled Trial vs. Daily Sublingual Buprenorphine-naloxone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jan 2022
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary) ; Buprenorphine/naloxone; Buprenorphine/naloxone
- Indications Opioid-related disorders
- Focus Proof of concept; Therapeutic Use
- 10 Mar 2021 Status changed from recruiting to completed.
- 21 Apr 2020 Planned End Date changed from 1 Aug 2020 to 1 Sep 2020.
- 21 Apr 2020 Planned primary completion date changed from 1 Aug 2020 to 1 Jun 2020.